Pfizer's Revenue by Region
In fiscal year 2025, Pfizer's revenue by geographical region are as follows:
- Developed Rest Of World: $16.19 B
- Emerging Markets: $9.31 B
- UNITED STATES: $37.08 B
Learn more about Pfizer’s Revenue by Products
Check out competitors to Pfizer in a side-by-side comparison.
Explore additional financial metrics for Pfizer.
Pfizer's Revenue Share by Region
| Developed Europe | 11650000000 |
|---|---|
| Developed Rest Of World | 7761000000 |
| Emerging Markets | 11996000000 |
| UNITED STATES | 27088000000 |
| Developed Rest Of World | 16057000000 |
|---|---|
| Emerging Markets | 8879000000 |
| UNITED STATES | 38691000000 |
| Developed Rest Of World | 16188000000 |
|---|---|
| Emerging Markets | 9313000000 |
| UNITED STATES | 37078000000 |
The above chart shows Pfizer's revenue percentage share by geographical region.
In fiscal year 2023, Pfizer's revenue by region is as follows:
- Developed Europe generated $11.65 B in revenue, representing 19.92% of its total revenue.
- Developed Rest Of World generated $7.76 B in revenue, representing 13.27% of its total revenue.
- Emerging Markets generated $12.00 B in revenue, representing 20.51% of its total revenue.
- UNITED STATES generated $27.09 B in revenue, representing 46.31% of its total revenue.
The biggest region for Pfizer is the UNITED STATES, which represents 46.31% of its total revenue.
The smallest region for Pfizer is the Developed Rest Of World, which represents 13.27% of its total revenue.
The above chart shows Pfizer's revenue percentage share by geographical region.
In fiscal year 2024, Pfizer's revenue by region is as follows:
- Developed Rest Of World generated $16.06 B in revenue, representing 25.24% of its total revenue.
- Emerging Markets generated $8.88 B in revenue, representing 13.95% of its total revenue.
- UNITED STATES generated $38.69 B in revenue, representing 60.81% of its total revenue.
The biggest region for Pfizer is the UNITED STATES, which represents 60.81% of its total revenue.
The smallest region for Pfizer is the Emerging Markets, which represents 13.95% of its total revenue.
The above chart shows Pfizer's revenue percentage share by geographical region.
In fiscal year 2025, Pfizer's revenue by region is as follows:
- Developed Rest Of World generated $16.19 B in revenue, representing 25.87% of its total revenue.
- Emerging Markets generated $9.31 B in revenue, representing 14.88% of its total revenue.
- UNITED STATES generated $37.08 B in revenue, representing 59.25% of its total revenue.
The biggest region for Pfizer is the UNITED STATES, which represents 59.25% of its total revenue.
The smallest region for Pfizer is the Emerging Markets, which represents 14.88% of its total revenue.
Summary Table
| Geography (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Developed Europe | 19.92% | 0% | 0% |
| Developed Rest Of World | 13.27% | 25.24% | 25.87% |
| Emerging Markets | 20.51% | 13.95% | 14.88% |
| UNITED STATES | 46.31% | 60.81% | 59.25% |
| Total Revenue | 100% | 100% | 100% |
Pfizer's Regions Revenue Trend
The above chart shows the revenue trend of different segments of Pfizer.
In fiscal year 2025, the UNITED STATES generated the most revenue ($37.08 B), and the Emerging Markets generated the least revenue ($9.31 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Region | 2023 | 2024 | 2025 |
|---|---|---|---|
| Developed Europe | $11.65 B - | - - | - - |
| Developed Rest Of World | $7.76 B - |
$16.06 B
106.89%
|
$16.19 B
0.82%
|
| Emerging Markets | $12.00 B - |
$8.88 B
25.98%
|
$9.31 B
4.89%
|
| UNITED STATES | $27.09 B - |
$38.69 B
42.83%
|
$37.08 B
4.17%
|
| Total Revenue | $58.50 B - |
$63.63 B
8.77%
|
$62.58 B
1.65%
|





